Overview

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects

Status:
Completed

Trial end date:
2008-12-12

Target enrollment:

Participant gender:

Summary

A first-time in human study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK1278863A in healthy subjects

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline